| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 608.648.442 $ | +143.485.461 $ | +473,5 % | 9 | 474.605.699 $ | +187.353.588 $ | +128,4 % | 9 | 469.385.378 $ | +148.080.451 $ | +40,0 % | 7 | ||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 155.105.193 $ | -16.439.160 $ | -9,6 % | 1 | 171.544.353 $ | +61.663.100 $ | +56,1 % | 1 | 109.881.253 $ | +48.538.203 $ | +79,1 % | 1 |
| GH Research PLC | GHRS | → 0 | Stark | 151.331.829 $ | +19.168.327 $ | +14,5 % | 1 | 132.163.502 $ | +27.851.823 $ | +26,7 % | 1 | 104.311.679 $ | +22.066.346 $ | +26,8 % | 1 |
| Merus N.V. | → 0 | 144.439.375 $ | +61.918.338 $ | +75,0 % | 1 | ||||||||||
| Cullinan Therapeutics, Inc. | CGEM | → 0 | Neutral | 127.371.335 $ | +34.599.110 $ | +37,3 % | 1 | 92.772.225 $ | +58.579.311 $ | +171,3 % | 1 | 34.192.914 $ | +1.054.574 $ | +3,2 % | 1 |
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 88.349.345 $ | +86.181.980 $ | +3.976,3 % | 1 | ||||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Stark | 46.501.930 $ | +5.988.246 $ | +14,8 % | 1 | ||||||||
| Denali Therapeutics Inc. | DNLI | → 0 | Stark | 36.101.818 $ | +7.395.056 $ | +25,8 % | 1 | 28.706.762 $ | +24.907.067 $ | +655,5 % | 1 | ||||
| C4 Therapeutics, Inc. | CCCC | → 0 | Neutral | 18.407.112 $ | +4.849.678 $ | +35,8 % | 1 | 13.557.434 $ | -2.200.421 $ | -14,0 % | 1 | 15.757.855 $ | +5.607.525 $ | +55,2 % | 1 |
| Korro Bio, Inc. | KRRO | → 0 | Schwach | 17.413.511 $ | +11.983.412 $ | +220,7 % | 1 | ||||||||
| TScan Therapeutics, Inc. | TCRX | → 0 | Neutral | 8.099.339 $ | +80.191 $ | +1,0 % | 1 | 8.019.148 $ | -6.281.224 $ | -43,9 % | 1 | 14.300.372 $ | +2.907.219 $ | +25,5 % | 1 |
| Xencor Inc | XNCR | → 0 | Schwach | 6.468.960 $ | -4.333.133 $ | -40,1 % | 1 | 10.802.093 $ | +10.802.093 $ | 1 | |||||
| Immatics N.V. | IMTX | → 0 | Neutral | 9.680.475 $ | +9.680.475 $ | 1 | |||||||||
| Passage BIO, Inc. | PASG | → 0 | Neutral | 7.359.707 $ | +2.351.364 $ | +46,9 % | 1 | ||||||||
| 608.648.442 $ | +143.485.461 $ | +473,5 % | 9 | 474.605.699 $ | +187.353.588 $ | +128,4 % | 9 | 469.385.378 $ | +148.080.451 $ | +40,0 % | 7 | ||||